Resposta imune a uma vacina protéica antimeningocócica B: estudo da influência de intervalos de tempo entre as imunizações

Gorla, Maria Cecília Outeiro.
São Paulo; s.n; 2003. [122] p. tab, graf.
Tese em Português | LILACS, SES-SP | ID: lil-385846

Documentos relacionados

  1. Meningococcal Vaccine in Mali and Gambia. Reply.
  2. Effectiveness of a Meningococcal Group B Vaccine (4CMenB) in Children.
  3. Propositive follow-up: Long-term immune responses to the 4CMenB and MenACWY vaccines in people living with HIV.
  4. Re-randomization tests as sensitivity analyses to confirm immunological noninferiority of an investigational vaccine: Case study.
  5. Variability of in vivo potency assays of whole-cell pertussis, inactivated polio, and meningococcal B vaccines.
  6. Meningococcal Group B Vaccine (4CMenB) in Children.
  7. Meningococcal Group B Vaccine (4CMenB) in Children. Reply.
  8. Quadrivalent meningococcal tetanus toxoid-conjugate booster vaccination in adolescents and adults: phase III randomized study.
  9. Meningococcal Vaccine in Mali and Gambia.
  10. Recognizing the Broader Value of Meningococcal Vaccination: A Matter of Evidence, Ability, or Willingness?